By Martin J. Stransky, MD, courtesy of The New Presence In the coming months, the current CoV19 epidemic will be increasingly viewed from a social, political, and economic perspective. Though the epidemic isn’t over yet, some telling conclusions can already be drawn regarding laws of human nature and our current society. […]
Author: Erik Sass
Targeting H-1B visas won’t help fight COVID-19, but will delay recovery
By Oliver McPherson-Smith, American Consumer Institute The COVID-19 pandemic has dealt a significant blow to America’s economy and countless Americans will be looking for jobs in the coming months. To ease competition in the labor force, four senators are pushing for a ban on certain temporary workers. But the plan would also block highly-educated […]
Hydroxychloroquine vs. COVID-19
HYDROXYCHLOROQUINE Research Bibliography & Digest The Economic Standard is gathering medical research about hydroxychloroquine as a treatment for COVID-19, alone or in combination with other drugs, published (or about to be published) in academic journals. Have a study? Submit citations with brief summaries, ideally from the text itself, via the submissions box below the […]
Putting Trump’s Treatment in Context
By Erik Sass, TES Editor-in-Chief On May 18, President Trump announced that he began taking a combination of hydroxychloroquine (HCQ), azithromycin, and zinc about 10 days prior. This was around the same time that multiple White House staffers were reported to have contracted the novel coronavirus. The President appears to be taking this […]
Washington Beyond the Headlines: Are Businesses Competing with Prison Labor?
By Andy Blom, TES Washington Editor The number one question in America this week is: When should we open? Thoughtful free market policy people are proposing ways to lead us out of this crisis…and some other crises as well. As Washington goes back to work…and considers spending a whole lot more of your money… […]
On vaccine, World Health Assembly putting cart before the horse
By Roger Bate, American Enterprise Institute (AEI) The World Health Assembly which begins today is the most important in living memory. Normally it lasts for a mind-numbingly boring week and addresses myriad issues, but this time it’s only taking two days, with the focus on Covid-19. NPR is setting this up as […]
Why was positive HCQ data removed from draft of BMJ paper?
On May 14, the British Medical Journal published an article presenting the results of a multi-center trial of hydroxychloroquine (HCQ) in Chinese patients with COVID-19 in February. It concluded: “Administration of hydroxychloroquine did not result in a significantly higher probability of negative conversion than standard of care alone in patients admitted to hospital […]
Bright vs. WHO: America Is Out of Step with the World on COVID-19 Treatment
By Erik Sass, Editor-in-Chief Sometimes the strange state of our reality can be summed up by two juxtaposed news items. Take this week’s bizarre exercise in cognitive dissonance: On the one hand, Rick Bright, the former director of the Biomedical Advanced Research and Development Authority, took a victory lap in front of Congress for […]
Hong Kong democracy movement still in China’s crosshairs
By Dr. Alexander Görlach, Senior Fellow, Carnegie Council for Ethics in International Affairs The aim is for Hong Kong to be like every other city in China: under the complete control of the Communist Party. Since the return of the former crown colony to the People’s Republic, the autonomous metropolis and hub of […]
Beware of trying to “make China pay” for COVID-19
“It Would Be Great to “Make China Pay” for COVID-19, But the Price Could Be High” By Doug Bandow, courtesy of the Cato Institute Many of us hoped that economic liberalization in China would encourage political reform. The country did change dramatically: Maoism was tossed into history’s trash bin, while personal autonomy and economic […]